Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Sioux Nation -- Ignore unavailable to you. Want to Upgrade?

To: Wharf Rat who wrote (99568)	2/15/2007 3:45:44 PM
From: Patricia Trinchero	Read Replies (1) \| Respond to of 361043

An article I just read stated that there are some taxonomic discrepencies in terms of the immunoserological properties and the fungal isolates may not be totally identical to the tropical species of Crypto. It might be a new serotype. Might, is the key word here. The experts aren't 100% sure. They treat the infection with Voriconazole and it can't be associated solely with immunocompromised patients or animals...............however, it appears to be zoonotic. Aspirgillis is more of a secondary invader type that thrives in immunocompromised patients. Specifically, transplant patients and patients undergoing large doses of chemotherapy. The disease is still being defined so new and different info may be discovered. pubmedcentral.nih.gov